Steven Rice

Former Executive Vice President and Chief Administrative OfficeratVir Biotechnology· In proxies 2021–2023

Pay in FY2023+45% from the year before · Vir Biotechnology stock -60.3% the same year

Steven Rice was paid $3.3M in FY2023 (Dec), up 45%. Vir Biotechnology stock fell 60.3% that year.

Pay$100 in the stock at the end of FY20 → $38

Pay is from the Summary Compensation Table of each Vir Biotechnology proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

Vir BiotechnologyPublic company · 5 yr
- Former Executive Vice President and Chief Administrative Officer2021 – Present · 5 yrStock in role -60%

Roles come from the proxy statements of each company.

Activity

Pay
Vir Biotechnology Former Executive Vice President and Chief Administrative Officer pay rose 45% to $3.3M. The stock fell 60% in FY2023 (Dec).
DEF 14AApr 19, 2024
Pay
Vir Biotechnology Former Executive Vice President and Chief Administrative Officer pay fell 47% to $2.2M. The stock fell 40% in FY2022 (Dec).
DEF 14AApr 19, 2024

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?